Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register - PubMed (original) (raw)
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register
G Haugeberg et al. Arthritis Rheum. 2000 Mar.
Free article
Abstract
Objective: To examine the bone mineral density (BMD), frequency of osteoporosis, and risk factors for BMD reduction in a representative population of female rheumatoid arthritis (RA) patients ages 20-70 years.
Methods: BMD in the femoral neck, total hip, and spine L2-4 (anterior-posterior view) was measured in 394 RA patients recruited from a validated county RA register (completeness 85%) comprising 721 women ages 20-70 years. BMD was measured with dual-energy x-ray absorptiometry, and age-specific values were compared with pooled values from a European/US population of healthy subjects free from earlier fractures, chronic diseases, and medications influencing bone metabolism. A multiple linear regression model was used to determine individual predictors of BMD.
Results: No statistically significant differences were found in demographic, disease activity, disease severity, or health status parameters between the RA register patients in whom BMD was measured and the remaining register patients. Femoral neck BMD was significantly reduced by 4.2% in the age group 50-59 years, and by 5.0% in those ages 60-70 years. For BMD in the total hip, the significant reductions were 3.7%, 6.0%, and 8.5% in the age groups 40-49 years, 50-59 years, and 60-70 years, respectively. No significant reduction in spine L2-4 BMD was found. A 2-fold increased frequency of osteoporosis was observed in all 4 age groups of RA patients compared with the reference population, ranging from 0% to 28.6% in the femoral neck, 0% to 29.9% in the total hip, and 1.8% to 31.5% in the spine. Predictors of reduced BMD were as follows: at the femoral neck, older age, low body weight, current use of corticosteroids, greater physical disability (as measured by the modified Health Assessment Questionnaire [M-HAQ]), and presence of rheumatoid factor; at the total hip, older age, low weight, current use of corticosteroids, and higher M-HAQ disability score; and at the lumbar spine, older age, low weight, and current use of corticosteroids.
Conclusion: Register-based prevalence data on BMD reduction in female RA patients ages 20-70 years are presented for the first time in this report, which demonstrates a 2-fold increase in osteoporosis in this representative population.
Similar articles
- Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register.
Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Haugeberg G, et al. Arthritis Rheum. 2000 Dec;43(12):2776-84. doi: 10.1002/1529-0131(200012)43:12<2776::AID-ANR18>3.0.CO;2-N. Arthritis Rheum. 2000. PMID: 11145036 - A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S. Sinigaglia L, et al. J Rheumatol. 2000 Nov;27(11):2582-9. J Rheumatol. 2000. PMID: 11093437 - Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.
Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF. Lodder MC, et al. Ann Rheum Dis. 2004 Dec;63(12):1576-80. doi: 10.1136/ard.2003.016253. Ann Rheum Dis. 2004. PMID: 15547081 Free PMC article. - [Osteoporosis in rheumatoid arthritis].
Suzuki Y, Uehara R, Ide M, Ichikawa Y. Suzuki Y, et al. Nihon Rinsho. 1998 Jun;56(6):1598-603. Nihon Rinsho. 1998. PMID: 9648488 Review. Japanese. - Osteoporosis in patients with rheumatic diseases.
Star VL, Hochberg MC. Star VL, et al. Rheum Dis Clin North Am. 1994 Aug;20(3):561-76. Rheum Dis Clin North Am. 1994. PMID: 7984778 Review.
Cited by
- Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis.
Kwon OC, Oh JS, Park MC, Kim YG. Kwon OC, et al. Front Med (Lausanne). 2020 Aug 21;7:443. doi: 10.3389/fmed.2020.00443. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32974365 Free PMC article. - Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease.
Ricciardi BF, Paul J, Kim A, Russell LA, Lane JM. Ricciardi BF, et al. Osteoporos Int. 2013 Feb;24(2):423-32. doi: 10.1007/s00198-012-2113-8. Epub 2012 Sep 7. Osteoporos Int. 2013. PMID: 22955310 Review. - The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review.
Chen PK, Tang KT, Chen DY. Chen PK, et al. Int J Mol Sci. 2024 Jan 3;25(1):626. doi: 10.3390/ijms25010626. Int J Mol Sci. 2024. PMID: 38203796 Free PMC article. Review. - Dual X-Ray Absorptiometry Whole Body Composition of Bone Tissue in Rheumatoid Arthritis - a Cross-Sectional Study.
Popescu C, Bojinca V, Opris D, Ionescu R. Popescu C, et al. Maedica (Bucur). 2015 Mar;10(1):19-26. Maedica (Bucur). 2015. PMID: 26225145 Free PMC article. - Hindlimb unloading causes regional loading-dependent changes in osteocyte inflammatory cytokines that are modulated by exogenous irisin treatment.
Metzger CE, Anand Narayanan S, Phan PH, Bloomfield SA. Metzger CE, et al. NPJ Microgravity. 2020 Oct 7;6:28. doi: 10.1038/s41526-020-00118-4. eCollection 2020. NPJ Microgravity. 2020. PMID: 33083525 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical